FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36887411000001109: Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113151001000001114 Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113151101000001110 Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has specific active ingredient Darvadstrocel true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Is a Darvadstrocel 30million cells/6ml suspension for injection vials true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has specific active ingredient Darvadstrocel false Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Is a Alofisel true Inferred relationship Existential restriction modifier
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Has active ingredient Human mesenchymal stem cell true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) 4 vial Has AMP True Alofisel 30million cells/6ml suspension for injection vials (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start